MAT2A-IN-6
MAT2A-IN-6 is a potent inhibitor of MAT2A. The expression level of MAT2A is abnormally elevated in several types of tumors, including gastric, colon, liver and pancreatic cancers. MAT2A-IN-6 reduces the proliferative activity of MTAP-deficient cancer cells. MAT2A-IN-6 has the potential for the potential for the research of cancer diseases (extracted from patent WO2021254529A1, compound 18) [1].
Product Specifications
CAS Number
2756458-72-5
UNSPSC
12352005
Target
Methionine Adenosyltransferase (MAT)
Type
Reference compound
Related Pathways
Epigenetics; Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/mat2a-in-6.html
Solubility
10 mM in DMSO
Smiles
O=C(C1=C(NC)C2=C(N(C3=CC=CC=C3Cl)C1=O)N=C(C(F)(F)F)C=C2)OC
Molecular Formula
C18H13ClF3N3O3
Molecular Weight
411.76
References & Citations
[1]Li Zhen, et al. Bicyclic compounds. Patent WO2021254529A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
MLNR, CT (MLNR, GPR38, MTLR, MTLR1, Motilin receptor, G-protein coupled receptor 38) (Biotin) discontinued
